Form 4: BeiGene Director Sells Shares
Insider Transaction (Form 4)
Xiaodong Wang, a Director of BeiGene, Ltd., sold 31,028 shares of common stock on September 28, 2026.
Summary
- Option exercise/conversion: acquired 31,028 American Depositary Shares at $36.90 ($1,144,933) on September 28, 2026; holds 31,028 after (Direct).
- Open-market sale: disposed of 160 American Depositary Shares at $356.97 ($57,115) on September 28, 2026; holds 30,868 after (Direct).
- Open-market sale: disposed of 120 American Depositary Shares at $358.71 ($43,045) on September 28, 2026; holds 30,748 after (Direct).
- Open-market sale: disposed of 40 American Depositary Shares at $359.16 ($14,366) on September 28, 2026; holds 30,708 after (Direct).
- Open-market sale: disposed of 2,241 American Depositary Shares at $361.05 ($809,120) on September 28, 2026; holds 28,467 after (Direct).
- Open-market sale: disposed of 4,239 American Depositary Shares at $362.17 ($1,535,228) on September 28, 2026; holds 24,228 after (Direct).
- Open-market sale: disposed of 3,499 American Depositary Shares at $363.10 ($1,270,485) on September 28, 2026; holds 20,729 after (Direct).
- Open-market sale: disposed of 3,419 American Depositary Shares at $364.07 ($1,244,747) on September 28, 2026; holds 17,310 after (Direct).
- Open-market sale: disposed of 2,047 American Depositary Shares at $365.85 ($748,891) on September 28, 2026; holds 15,263 after (Direct).
- Open-market sale: disposed of 14,525 American Depositary Shares at $366.58 ($5,324,550) on September 28, 2026; holds 738 after (Direct).
- Open-market sale: disposed of 738 American Depositary Shares at $367.23 ($271,012) on September 28, 2026 (Direct).
- Option exercise/conversion: disposed of 403,364 Share Option (Right to Buy) on September 28, 2026; holds 806,715 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $11,318,558 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Xiaodong Wang — Director, Other (Chair, Scientific Advisory Brd)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Option exercise/conversion | American Depositary Shares | 31,028 | $37 | $1.1M | 31,028 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 160 | $357 | $57.1K | 30,868 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 120 | $359 | $43.0K | 30,748 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 40 | $359 | $14.4K | 30,708 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 2,241 | $361 | $809.1K | 28,467 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 4,239 | $362 | $1.5M | 24,228 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 3,499 | $363 | $1.3M | 20,729 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 3,419 | $364 | $1.2M | 17,310 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 2,047 | $366 | $748.9K | 15,263 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 14,525 | $367 | $5.3M | 738 |
| 2026-09-28 | Open-market sale | American Depositary Shares | 738 | $367 | $271.0K | 0 |
| 2026-09-28 | Option exercise/conversion | Share Option (Right to Buy) | 403,364 | — | — | 806,715 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Option exercise/conversion (31,028 shares) |
| 2026-09-28 | Open-market sale (160 shares) |
| 2026-09-28 | Open-market sale (120 shares) |
| 2026-09-28 | Open-market sale (40 shares) |
| 2026-09-28 | Open-market sale (2,241 shares) |
| 2026-09-28 | Open-market sale (4,239 shares) |
| 2026-09-28 | Open-market sale (3,499 shares) |
| 2026-09-28 | Open-market sale (3,419 shares) |
| 2026-09-28 | Open-market sale (2,047 shares) |
| 2026-09-28 | Open-market sale (14,525 shares) |
| 2026-09-28 | Open-market sale (738 shares) |
| 2026-09-28 | Option exercise/conversion (403,364 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Xiaodong Wang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.